Clinical trial
BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma
NCT00022542 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00022542 |
|---|---|
| Title | BMS-247550 in Treating Patients With Advanced Soft Tissue Sarcoma |
| Official title | A Phase II Study of Epothilone B Analog (BMS-247550) in Advanced Soft Tissue Sarcomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma |
| Intervention type | Drug |
| Interventions | ixabepilone |
| Enrollment | 26 |
| Start date | Jun 1, 2001 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Feb 27, 2004 |
| Last update posted | Apr 15, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: